Beyond Suppression: Why Your Body's Natural Recovery Process Deserves More Attention

For decades, supporting the body's response to everyday physical stress has focused almost exclusively on one side of the equation: what happens at the onset. But a growing body of research is revealing that the body's ability to complete its natural recovery process — not merely manage the initial response — may be the more critical factor in how your patients feel and function long-term.

The body's response to physical stress is not a single event. It is a tightly orchestrated process with two distinct phases: the initial reactive phase and a resolution phase, during which the body actively restores balance. While the first phase is well understood, research pioneered by Dr. Charles Serhan at Harvard has demonstrated that resolution is not passive. It requires its own class of endogenous signaling molecules: Specialized Pro-Resolving Mediators, or SPMs.¹

SPMs — including resolvins, protectins, and maresins — are enzymatically derived from omega-3 fatty acids (EPA, DHA, and DPA). Rather than simply dampening the body's initial response, SPMs actively guide the return to homeostasis: supporting healthy immune cell activity, promoting the clearance of cellular debris, and signaling tissue repair and renewal pathways.² Importantly, these mediators work with the body's natural processes rather than against them — actively promoting specific biological pathways that restore normal function.³

When resolution stalls, the body can remain in a prolonged reactive state, which over time may affect comfort, mobility, energy, and overall quality of life.⁴ Research suggests that the body's ability to produce SPMs can be compromised by age, diet, and ongoing physical demands.⁵

The challenge is that many patients, particularly those with the greatest need for recovery support, cannot efficiently convert standard omega-3 supplementation into the specific precursor metabolites that fuel SPM production.

Biomega-SPM™ from Biotics Research has been designed to address precisely this gap. Delivering an industry-leading 500 µg per serving of SPM precursors through proprietary supercritical extraction with 8-stream fractionation, Biomega-SPM provides 7 identified precursors to SPMs — including 18-HEPE, 17-HDHA, and 7-HDPA — that support the body's resolution phase.* This comprehensive, multi-precursor approach promotes joint and muscular comfort, healthy tissue repair, and balanced immune support* — giving your patients the building blocks their bodies need to complete the recovery process, not just begin it.

References:

1. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92-101.
2. Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016;16(1):51-67.
3. Perna S, et al. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications. Int J Mol Sci. 2022;23(9):4875.
4. Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J. 2011;437:185-197.
5. Chiang N, Serhan CN. Specialized pro-resolving mediator network: An update on production and actions. Essays Biochem. 2020;64:443-462.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.